|
⚲
|
| Keyboard |
| Glenn Scott L
✚
|
|
|---|---|
| CIK # | 0001284095 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001284095] | |
| 4 | [0001284095] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Glenn Scott L | |
| Evoke Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Evoke Pharma Inc EVOK
Stock Option (Right to Buy) · derivative
|
2018-04-26 | Grant | 32,500 | $0.00 | |
|
Evoke Pharma Inc EVOK
Stock Option (Right to Buy) · derivative
|
2017-05-03 | Grant | 32,500 | $0.00 | |
|
Evoke Pharma Inc EVOK
Stock Option (Right to Buy) · derivative
|
2016-04-27 | Grant | 17,500 | $0.00 | |
|
Evoke Pharma Inc EVOK
Stock Option (Right to Buy) · derivative
|
2015-04-22 | Grant | 9,000 | $0.00 | |
|
Evoke Pharma Inc EVOK
Stock Option (Right to Buy) · derivative
|
2014-05-20 | Grant | 9,000 | $0.00 | |
|
Evoke Pharma Inc EVOK
Series A Preferred Stock · derivative
|
2013-09-30 | Conversion | 78,027 | ||
|
Evoke Pharma Inc EVOK
Common Stock
|
2013-09-30 | Conversion | 15,605 | ||
|
Evoke Pharma Inc EVOK
Stock Option (Right to Buy) · derivative
|
2013-09-24 | Grant | 18,000 | $0.00 |